FDA Documents of Boehringer Ingelheim Roxane, Inc.
Boehringer Ingelheim Roxane, Inc. is an organization that has been audited by the FDA 49 times between 2000 and 2015 across all 4 sites.
Documents
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2014
Out-of-stock
Issued on: Jun 26, 2014
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2011
Out-of-stock
Issued on: Jan 20, 2011
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2010
Out-of-stock
Issued on: Dec 3, 2010
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2010
Out-of-stock
Issued on: Feb 24, 2010
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2009
Out-of-stock
Issued on: May 6, 2009
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2008
Out-of-stock
Issued on: Sep 17, 2008
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2008
Out-of-stock
Issued on: May 22, 2008
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2006
Out-of-stock
Issued on: Sep 29, 2006
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2005
Out-of-stock
Issued on: Aug 25, 2005
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Danbury | 2005
Out-of-stock
Issued on: Jun 24, 2005
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2005
Out-of-stock
Issued on: Apr 19, 2005
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2005
Out-of-stock
Issued on: Jan 12, 2005
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2004
Out-of-stock
Issued on: Feb 13, 2004
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2003
Out-of-stock
Issued on: Nov 18, 2003
Human Drug Form 483
FDA 483 Boehringer Ingelheim Roxane, Inc., Columbus | 2003
Out-of-stock
Issued on: Apr 18, 2003
Medical Devices & Rad Health Form 483
FDA Investigators(29)
- Christopher T. Middendorf, FDA Investigator
- Bryce A. Hammer, FDA Investigator
- Djamila Harouaka, FDA Investigator
- Joshua P. Wireman, FDA Investigator
- Matthew B. Casale, FDA Investigator
- Nicholas L. Paulin, FDA Investigator
- Dell S. Moller, FDA Investigator
- Joshua S. Hunt, FDA Investigator
- Jeffrey J. Thibodeau, FDA Investigator
- Mark R. McClain, FDA Investigator
- Hugh M. McClure, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Andria L. Kuhlman, FDA Investigator
- Michael P. Sheehan, FDA Investigator
- Kelli Wilkinson, FDA Investigator
- Mary E. Storch, FDA Investigator
- Phillip M. Pontikos, FDA Investigator
- Michelle M. Noe, FDA Investigator
- Anthony C. Warchut, FDA Investigator
- Mark E. Parmon, FDA Investigator
- Ted L. Anderson, FDA Investigator
- Matthew H. Pitts, FDA Investigator
- Anthony N. Onianwa, FDA Investigator
- Charles C. Conn Iii, FDA Investigator
- Conn Iii, Charles C, FDA Investigator
- Jeffrey A. Sincek, FDA Investigator
- Frederick M. Lochner, FDA Investigator
- Karen M. Kondas, FDA Investigator
- Tyra S. Wisecup, FDA Investigator